The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients.

Aliénor XhaardElsa MiekoutimaFrance PirenneAnne FrançoisPierre TiberghienMarie SebertLionel AdèsPierre FenauxAnne-Claire Leprêtre

Published in: Vox sanguinis (2022)

Allowing the transfusion of non-PAM RBC in selected chronically transfused MDS and AML patients was feasible and enabled to redistribute infrequent phenotypes RBC units to other patients in need.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
red blood cell
acute myeloid leukemia
cardiac surgery
intensive care unit
bone marrow
liver failure
acute lymphoblastic leukemia
hepatitis b virus
patient reported
sickle cell disease
drug induced
acute respiratory distress syndrome